AST’s latest whitepaper on robotics, published in full on the Pharmaceutical Online website<\/p>\n\n\n\n
By Steven Ng and Spencer Bolte, Automated Systems of Tacoma<\/p>\n\n\n\n
Innovations in drug development and manufacturing, as well as the technologies used to bring them to market, have led to exciting discoveries in patient treatment. For example, the ability to tailor therapies to the individual patient by using molecular and genomic drivers is bridging the gap between medicine and unmet clinical needs for rare and orphan diseases. Not only is this drastically changing the pipeline of many companies, but it is also leading to smaller batch sizes and more frequent recipe changeovers, profoundly impacting how drugs are produced. Manufacturers are looking for solutions to optimize operations to improve efficiency and reduce cost while enhancing quality.<\/p>\n\n\n\n
To read the full article, please click the link below:<\/p>\n\n\n\n